| Application no. and date | 10003365.3 (espacenet) (Federated) (European Patent Register), 20030905 | | Patent/reg. no. and date | DK/EP 2213685, 20131127 | | Publication date | 20100804 | | Priority no. and date | US 408719, 20020906 | | EP pub. no. and date |
EP 2213685 20100804 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US,
E. R. Squibb & Sons, L.L.C., Route 206 & Province Line Road
Princeton, NJ 08540, US | | Applicant ref. no. | MEDIMMUNE IL1R-103EP2 | | Inventor | VARNUM, Brian, 602 12th Street
Santa Monica, CA 90402, US,
ELLIOTT, Gary, 2458 Chaucer Place
Thousand Oaks, CA 91362, US,
WITTE, Alison, 3505 Bean Creek Road
Scotts Valley, CA 95066, US,
HUANG, Haichun, 4329 Crestwood Street
Fremont, CA 94538, US,
Vezina, Chris, 351 Greenaway Avenue
Newbury Park, CA 91320, US,
Qian, Xueming, 596 Myrtle Court
Oak Park, CA 91377, US,
Martin, Francis, 865 Fernhill Court
Newbury Park, CA 91320, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | Terapeutisk anti-IL-1R1-monoklonalt antistof | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
